Yearly Archives: 2021

Government of Canada Enters into a Manufacturing Production Agreement “Memorandum of Understanding” with Novavax (NVAX-$264, NASDAQ).

“That was a Shrewdly Negotiated Deal on behalf of the Government of Canada”….Said no one, Ever. The US public is often critical of the American federal and state response to the Covid-19 pandemic. In comparison to the actions undertaken by

Posted in Portfolio Model Subscription

Novavax (NVAX-$220.84, NASDAQ) Acquired for the Model Portfolio.

As a collector, it occasionally pains me to consider parting with an item. Sometimes, the thought process involved produces a dull, persistent headache until a decision is made. Conversely, when a recently discovered, newly authenticated, Caravaggio comes up for auction

Posted in Portfolio Model Subscription

Moderna (MRNA-$173.16, NASDAQ) Asks FDA to Permit Labelling to Allow for a 15 Dose Per Vial Designation.

Moderna has applied to the FDA to permit each vial of Covid-19 vaccine to hold 15 doses, rather than the current labelling of 10 doses. For the media, the public relations statement is that by allowing each vial to hold

Posted in Portfolio Model Subscription

Novavax (NVAX-$218.76, NASDAQ) Covid-19 Vaccine Looks Quite Encouraging: Johnson and Johnson Covid-19 Vaccine (JNJ-$163.55, NYSE), Much Less so.

https://www.barrons.com/articles/novavax-stock-soars-as-its-covid-19-vaccine-outperforms-j-js-51611930639?siteid=yhoof2 Novavax might be a takeover candidate by one of the large pharma companies, based upon this initial indication.

Posted in Portfolio Model Subscription

BJ’s Wholesale Club Holdings (BJ-$49.32, NYSE) Enters into Point of Sale Finance Agreement With Citizens Bank (CFG-$35.27, NYSE).

https://investor.citizensbank.com/about-us/newsroom/latest-news/2021/2021-01-27-120053615.aspx

Posted in Portfolio Model Subscription
Recent Comments
    Archives